GCNA-Cluster: A Gene Co-Expression Network Alignment to Cluster Cancer Patients Algorithm for Identifying Subtypes of Pancreatic Ductal Adenocarcinoma.

Cancer heterogeneity makes it necessary to use different treatment strategies for patients with the same pathological features. Accurate identification of cancer subtypes is a crucial step in this approach. The current studies of pancreatic ductal adenocarcinoma (PDAC) subtypes mainly focus on single genes and ignore the synergistic effects of genes.

RSC-based differential model with correlation removal for improving multi-omics clustering.

Multi-omics clustering plays an important role in cancer subtyping. However, the data of different kinds of omics are often related, these correlations may reduce the clustering algorithm performance. It is crucial to eliminate the unexpected redundant information caused by these correlations between different omics.

A 70‑RNA model based on SVR and RFE for predicting the pancreatic cancer clinical prognosis.

Researches on the prognosis of pancreatic cancer is of great significance to improve the patient treatment effect and survival. Current researches mainly focus on the prediction of the survival status and the determination of prognostic markers. Each patient has its own characteristics, there is no report about the prediction of survival time.

Identification of subtype specific biomarkers of clear cell renal cell carcinoma using random forest and greedy algorithm.

Suitable biomarkers can be good indicator for cancer subtype. To find biomarkers that can accurately distinguish clear cell renal cell carcinoma (ccRCC) subtypes, we first determined ccRCC subtypes based on the expression of mRNA, miRNA and lncRNA, named clear cell type 1 (ccluster1) and 2 (ccluster2), using three unsupervised clustering algorithms. Besides being associated with the expression pattern derived from the single type of RNA, the differences between subtypes are relevant to the interactions between RNAs.